Quest Diagnostics Acquires California Laboratory Associates
News Oct 31, 2017
Quest Diagnostics announced it has acquired certain assets of California Laboratory Associates (CLA), a clinical lab network serving patients and providers in the Greater Los Angeles Area.
CLA's operations and patients were previously supported by caregivers and the laboratory at Providence Saint Joseph Medical Center in Burbank. More physicians and patients can now benefit from access to Quest's advanced and general diagnostic test services, and an expanded network of conveniently located patient service centers.
"We look forward to bringing Quest's insights and innovations to more individuals and providers in Southern California," said Steve Rusckowski, Chairman, President and CEO, Quest Diagnostics. "This acquisition will deepen our presence and ability to serve the region, while advancing our strategy to accelerate growth and drive operational excellence through strategically aligned, accretive acquisitions."
Quest will add several CLA patient service centers to its network in the San Fernando Valley and neighboring communities. Providence Saint Joseph will continue to operate its lab for hospital patients and certain outside physician services.
"Providence caregivers who have supported CLA's operations and patients have provided exemplary service across the Greater Los Angeles Area, helping to care for patients and coordinating with provider offices to ensure quality laboratory services," said Erik G. Wexler, Chief Executive, Providence St. Joseph Health, Southern California Region. "We are confident Quest Diagnostics will carry on the high standards our caregivers set in providing quality and compassionate care."
Scientists have identified sodium glucose transporter 2 (SGLT2) as a mechanism that lung cancer cells can utilize to obtain glucose, which is key to their survival and promotes tumor growth. The finding provides evidence that SGLT2 may be a novel biomarker that scientists can use to help diagnose precancerous lung lesions and early-stage lung cancers.READ MORE